Nasal irrigation with licorice extract (Glycyrrhiza glabra) in treating nasal polyps by reducing fibroblast differentiation and extracellular matrix production in TGF-β1-stimulated nasal polyp-derived fibroblasts by inhibiting the MAPK/ERK-1/2 pathway – an in vitro and in clinic study
Tóm tắt
To date, treating nasal polyps (NPs) is still a medical challenge. However, we have developed an innovative therapy using licorice extract (LE: Glycyrrhiza glabra) to treat rhinitis and sinusitis via nasal irrigation and have discovered that it significantly affects treatment of NPs. This study investigated the mechanism of LE on NPs. NPs were collected from three patients using tissue biopsies before and 2 weeks after nasal irrigation with licorice for histopathological analysis. Additionally, NPs from two patients were collected, and nasal polyp-derived fibroblasts (NPDF) were isolated and cultured. The TGF-β1-stimulated NPDF model was used to examine the effect of LE on fibroblast differentiation (biomarker: α-SMA), the consequent production of extracellular matrix (ECM; biomarkers: fibronectin, FBN), and the functional signaling pathway. Immunohistochemistry (IHC) revealed that the number of eosinophils and the expression of α-SMA and interstitial collagen of polyps after licorice treatment significantly decreased. Additionally, RT-PCR, western blotting, and immunofluorescence (IF) showed that α-SMA and FBN expressions were significantly increased in the NPDF, which was stimulated by TGF-β1, and LE dose-dependently could effectively reduce this effect. Furthermore, western blotting showed that LE could attenuate α-SMA and FBN expressions by preventing the signaling pathway of MAPK/ERK-1/2, which IHC and IF further confirmed. In addition, LE effectively suppressed the cell migration of NPDF, which is related to polyp expansion. LE is clinically used to treat sinusitis with NPs through nasal irrigation, which significantly reduces the size of NPs. This effect could attenuate fibroblast differentiation, ECM production and cell migration, and one of the functional mechanisms may be through inhibition of the MAPK/ERK-1/2 signaling pathway. ISRCTN (No. 51425529) registered on 17/04/2020 (retrospectively registered) -
http://www.isrctn.com/ISRCTN51425529
Tài liệu tham khảo
Hulse KE, Stevens WW, Tan BK, Schleimer RP. Pathogenesis of nasal polyposis. Clin Exp Allergy. 2015;45(2):328–46.
Hopkins C. Chronic Rhinosinusitis with nasal polyps. N Engl J Med. 2019;381(1):55–63.
Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2 Suppl):S1–S39.
Rimmer J, Fokkens W, Chong LY, Hopkins C. Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database Syst Rev. 2014;12:CD006991.
Vlaminck S, Acke F, Prokopakis E, Speleman K, Kawauchi H, van Cutsem JC, et al. Surgery in nasal polyp patients: outcome after a minimum observation of 10 years. Am J Rhinol Allergy. 2021;35(4):449–57.
Amedee RG. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Am J Rhinol Allergy. 2017;31(4):278.
Zhu L, Zhang H, Hu J, Ying L, Shan Y, Zhu Z, et al. Revision endoscopic sinus surgery and combined therapy for recurrent sinusitis. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009;23(11):488–90.
Damask C, Chen M, Holweg CTJ, Yoo B, Millette LA, Franzese C. Defining the efficacy of Omalizumab in nasal polyposis: a POLYP 1 and POLYP 2 subgroup analysis. Am J Rhinol Allergy. 2021;19458924211030486:1.
Kassem F, Cohen-Confino R, Meir-Shafrir K, Lachover-Roth I, Cohen-Engler A, Nageris B, et al. Mepolizumab for eosinophilic chronic sinusitis with nasal polyposis: real-life experience. Rhinology. 2021;59(1):110–2.
Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P, et al. Effect of subcutaneous Dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315(5):469–79.
Peters AT, Spector S, Hsu J, Hamilos DL, Baroody FM, Chandra RK, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014;113(4):347–85.
Tang LX, Gao J, Zhang YM. Budesonide saline nasal irrigation in treatment of children rhino-sinusitis. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;30(12):952–4.
Chang GH, Lin YS, Hsu KH, Cheng YC, Yang PR, Tsai MS, et al. Nasal irrigation with Glycyrrhiza glabra extract for treatment of allergic rhinitis - a study of in vitro, in vivo and clinical trial. J Ethnopharmacol. 2021;275:114116.
Kim SJ, Park JH, Lee SA, Lee JG, Shin JM, Lee HM. All-trans retinoic acid regulates TGF-beta1-induced extracellular matrix production via p38, JNK, and NF-kappaB-signaling pathways in nasal polyp-derived fibroblasts. Int Forum Allergy Rhinol. 2020;10(5):636–45.
Ryu NH, Shin JM, Um JY, Park IH, Lee HM. Wogonin inhibits transforming growth factor beta1-induced extracellular matrix production via the p38/activator protein 1 signaling pathway in nasal polyp-derived fibroblasts. Am J Rhinol Allergy. 2016;30(4):128–33.
Figueiredo CR, Santos RP, Silva ID, Weckx LL. Microarray cDNA to identify inflammatory genes in nasal polyposis. Am J Rhinol. 2007;21(2):231–5.
Little SC, Early SB, Woodard CR, Shonka DC Jr, Han JK, Borish L, et al. Dual action of TGF-beta1 on nasal-polyp derived fibroblasts. Laryngoscope. 2008;118(2):320–4.
Liu X, Wang X, Chen L, Shi Y, Wei Y. Effects of erythromycin on the proliferation and apoptosis of cultured nasal polyp-derived cells and the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) signaling pathway. Med Sci Monit. 2018;24:8048–55.
Moon YM, Park IH, Cho JS, Um JY, Kim TH, Lee HM. Berberine inhibits myofibroblast differentiation in nasal polyp-derived fibroblasts via the p38 pathway. Phytother Res. 2013;27(1):16–20.
Park IH, Park SJ, Cho JS, Moon YM, Kim TH, Lee SH, et al. Role of reactive oxygen species in transforming growth factor beta1-induced alpha smooth-muscle actin and collagen production in nasal polyp-derived fibroblasts. Int Arch Allergy Immunol. 2012;159(3):278–86.
Karthikkeyan G, Pervaje R, Pervaje SK, Prasad TSK, Modi PK. Prevention of MEK-ERK-1/2 hyper-activation underlines the neuroprotective effect of Glycyrrhiza glabra L. (Yashtimadhu) against rotenone-induced cellular and molecular aberrations. J Ethnopharmacol. 2021;274:114025.
Wu Z, Wang Z, Xie Z, Zhu H, Li C, Xie S, et al. Glycyrrhizic acid attenuates the inflammatory response after spinal cord injury by inhibiting high mobility group Box-1 protein through the p38/Jun N-terminal kinase signaling pathway. World Neurosurg. 2022;158:e856–64.
Yin Z, Zhu W, Wu Q, Zhang Q, Guo S, Liu T, et al. Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-kappaB, ERK, and JNK signaling pathways. Eur J Pharmacol. 2019;859:172550.
Zhang WY, Gu YC, Tang Y, Wu QZ. Effects of glycyrrhizic acid on ERK1/2 and p38 MAPK signaling pathway in a murine model of asthma. Zhonghua Yi Xue Za Zhi. 2018;98(16):1273–8.
Kim DK, Jin HR, Eun KM, Mutusamy S, Cho SH, Oh S, et al. Non-Eosinophilic nasal polyps shows increased epithelial proliferation and localized disease pattern in the Early stage. PLoS One. 2015;10(10):e0139945.
Gitomer SA, Fountain CR, Kingdom TT, Getz AE, Sillau SH, Katial RK, et al. Clinical examination of tissue eosinophilia in patients with chronic Rhinosinusitis and nasal polyposis. Otolaryngol Head Neck Surg. 2016;155(1):173–8.